Inari Medical, Inc. (NARI)
NASDAQ: NARI · IEX Real-Time Price · USD
45.75
-0.55 (-1.19%)
May 17, 2024, 4:00 PM EDT - Market closed
Inari Medical Revenue
Inari Medical had revenue of $520.66M in the twelve months ending March 31, 2024, with 26.10% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $143.19M with 23.27% year-over-year growth. In the year 2023, Inari Medical had annual revenue of $493.63M with 28.73% growth.
Revenue (ttm)
$520.66M
Revenue Growth
+26.10%
P/S Ratio
5.12
Revenue / Employee
$400,507
Employees
1,300
Market Cap
2.67B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 493.63M | 110.16M | 28.73% |
Dec 31, 2022 | 383.47M | 106.49M | 38.45% |
Dec 31, 2021 | 276.98M | 137.31M | 98.31% |
Dec 31, 2020 | 139.67M | 88.54M | 173.17% |
Dec 31, 2019 | 51.13M | 44.30M | 648.70% |
Dec 31, 2018 | 6.83M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Evolent Health | 2.18B |
Progyny | 1.11B |
PTC Therapeutics | 927.56M |
Azenta | 651.76M |
Certara | 360.69M |
TG Therapeutics | 289.33M |
Twist Bioscience | 277.49M |
MorphoSys AG | 264.75M |
NARI News
- 11 hours ago - IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Encourages Investors in Inari Medical, Inc. with Losses to Contact the Firm - Accesswire
- 11 hours ago - IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Encourages Investors in Inari Medical, Inc. with Losses to Contact the Firm - Accesswire
- 1 day ago - INARI MEDICAL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARI - PRNewsWire
- 1 day ago - Inari Medical, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - NARI - Accesswire
- 1 day ago - Shareholders of Inari Medical, Inc. Should Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your Rights - NARI - Accesswire
- 1 day ago - Inari Medical, Inc. Investor Notice: Robbins LLP Remind Stockholders of the NARI Securities Fraud Class Action - Business Wire
- 1 day ago - Inari Medical, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 12, 2024 to Discuss Your Rights - NARI - Accesswire
- 1 day ago - Levi & Korsinsky Reminds Inari Medical, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 12, 2024 - NARI - Accesswire